CARLSBAD, Calif., Jan. 28 /PRNewswire/ -- GenVault Corporation today announces that Mr. Mark Ostrowski has joined GenVault as its Vice President of Sales and Marketing. Mr. Ostrowski will be responsible for overseeing the growth and operation of GenVault’s domestic and international sales and marketing efforts in support of the substantial momentum for sustainable biosample storage and transport.
Mr. Ostrowski has more than 17 years experience in biotechnology sales and marketing. Mr. Ostrowski spent more than 10 years at Myriad Genetics Laboratories Inc., where he was most recently Director of Sales Operations, leading a team of sales professionals to commercialize state-of-the-art clinical predictive technologies for personalized medicine. At Myriad, Mr. Ostrowski planned and directed a 200 person sales organization that generated an average annual compound growth rate of 54% over the last decade. Prior to Myriad, Mr. Ostrowski’s efforts at Dianon Systems (a company purchased by Laboratory Corporation of America) included commercialization of pathology and oncology diagnostics to clinicians and healthcare organizations. Mr. Ostrowski holds a bachelor of science in biology from Yale University.
“Mark brings great commercialization experience and strong management skills to GenVault,” said David Wellis, GenVault President and CEO. “He has a proven ability to grow businesses with defining technologies which is ideally suited to leverage the tremendous progress GenVault has experienced this past year. We are all very excited to have him join our senior management team.”
About GenVault
GenVault is the global leader in providing biosample workflow, transport, and storage solutions for genomic medicine, discovery and identification. Today, GenVault is empowering over 150 pharmaceutical companies, medical centers, academic institutions and law enforcement agencies to more fully leverage the rapidly growing genomics industry. As a scalable and reliable alternative to traditional freezers and DNA purification systems, the company’s dry-state platform enables the extraction, preservation, recovery, and distribution of DNA at room temperature. Future systems will also accommodate proteins and RNA to provide a comprehensive solution. From GenPlate to the Dynamic Archive, GenVault is continuously developing and refining best practices for DNA sample management and preservation. For more information visit GenVault at http://www.genvault.com.
kmcweeny@genvault.com
CONTACT: Kerri McWeeny of GenVault Corporation, +1-760-268-5257,
kmcweeny@genvault.com
Web site: http://www.genvault.com/
